Close Menu

NEW YORK (GenomeWeb) – GlaxoSmithKline and 23andMe announced today that they have signed a four-year drug discovery collaboration deal in which both partners will initially contribute 50 percent of the funding, will have the ability to advance targets together or independently, and will share in the proceeds from any new drugs developed within the partnership.

Additionally, GSK said it has made a $300 million equity investment in 23andMe.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

A study of Great Danes homes in on a genomic region linked to fearfulness.

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.